ANN ARBOR, Mich., May 13, 2025 /PRNewswire/ -- Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announces the broad integration capability of its flagship product, ...
The MarketWatch News Department was not involved in the creation of this content. ANN ARBOR, Mich., Jan. 8, 2026 /PRNewswire/ -- Akadeum Life Sciences, the leader in buoyant microbubble cell ...
ANN ARBOR, Mich., Nov. 18, 2025 /PRNewswire/ -- Akadeum Life Sciences, the leader in buoyant cell separation, announced today that it has submitted a Type II Drug Master File (DMF) to the U.S. Food ...
DALLAS, Jan. 21, 2025 /PRNewswire/ -- Akadeum Life Sciences(R)' successful early access program for the Alerion(TM) Microbubble Cell Separation System confirmed the Alerion(TM) to be the highest ...
ANN ARBOR, Mich., Oct. 30, 2019 /PRNewswire-PRWeb/ -- Akadeum Life Sciences, Inc., an Ann Arbor-based biotechnology company, announced today that it has entered into a collaboration with Agilent ...
ANN ARBOR, Mich., Dec. 9, 2025 /PRNewswire/ -- Akadeum Life Sciences, the leader in buoyant cell separation, announces the establishment of the Akadeum CDMO Alliance™ and the first two members in the ...
ANN ARBOR, Mich., Aug. 29, 2023 /PRNewswire/ -- Akadeum Life Sciences, the global leaders in buoyancy-based cell separation technology, have today announced the release of their 'Human T Cell ...
Akadeum Life Sciences is pioneering buoyancy-based separation technologies that enable more effective and scalable cell isolation. Our mission is to create separation technologies to advance human ...
Akadeum is unveiling this advancement and attending alongside partners at the American Society of Gene & Cell Therapy (ASGCT) 2025 Annual Meeting in New Orleans, May 13th-16 th. Throughout the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results